NEWS FEED & ADDITIVE MAGAZINE February 2024 87 Pavo, ForFarmers’ organisation in the equine sector worldwide, is expanding its market position through the acquisition of Thunderbrook Equestrian Limited, a company operating mainly in the UK and Ireland. ForFarmers UK Holdings Ltd. acquires 100% of Thunderbrook's shares. Thunderbrook is a strong brand with a broad product portfolio consisting of conventional and organic feed products, supplements, and herbs for horses and ponies. Thunderbrook, with a turnover of GBP 3 million in 2023, has over the years built a wide distribution network in the UK and Ireland, consisting of specialist wholesalers and retailers in the UK and Ireland. Thunderbrook also has a strong online position. According to ForFarmes, all this offers prospects for further growth for Thunderbrook in the UK and Ireland. ForFarmers stated that Thunderbrook's product range fits seamlessly with Pavo's, a range sold in more than 30 countries. Both Pavo and Thunderbrook develop their product concepts but outsource feed production to ForFarmers and third parties. The acquisition will give Pavo access to Thunderbrook's extensive distribution network. Read more>> Pavo strengthens market position through acquisition of Thunderbrook in UK Axitan UK Limited, one of the leading biotech companies focused on the development of endolysin enzyme products to replace antibiotics in animal feed, announced the appointment of Alfred (Al) Zimmerman as its new Chief Executive Officer. Zimmerman brings a wealth of experience from the biotech and animal feed additive industries to Axitan. Axitan’s founder and former CEO, Dr. Kane Miller, will continue to lead the expansion of the company’s technology platform and associated end-market products in the newly formed position of Chief Innovation Officer. Dr. Kane Miller, founder, and Chief Innovation Officer, said: “Al’s industry insight and proven track record of building businesses within the animal feed sector bring the right balance to Axitan’s senior management team as we transition into the full commercialization phase. His enthusiasm for introducing new technologies and products, combined with his commercial and operating experience, will be instrumental in driving Axitan’s commercialization efforts for our endolysin platform and products.” Zimmerman was previously with Novus International from 2015-2023 and recently led innovation growth strategy, business development, acquisitions, and alliances. Before Novus, Zimmerman established and led the Dietary Supplement Finished Format Business at DuPont (now IFF). During his tenure at DuPont, which was focused on developing probiotics for humans and animals, he oversaw the development of the probiotic manufacturing platform within the US and the finished format manufacturing platform globally. Read more>> Axitan appoints seasoned industry leader as CEO Alfred Zimmerman
RkJQdWJsaXNoZXIy MTUxNjkxNQ==